Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Research Study for Type 2 Diabetes Mellitus Through Digital Therapeutics

NCT06810986 is registered in ClinicalTrials.gov with EVYD Technology as lead sponsor.

NCT NCT06810986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06810986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Research Study for Type 2 Diabetes Mellitus Through Digital Therapeutics
Lead sponsor
EVYD Technology
Phase
Not applicable
Overall status
Recruiting
Start date
August 20, 2024
Completion date
July 31, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus (t2dm)